(Press-News.org) Phoenix, AZ (April 14, 2015) - Researchers have characterized three different brain imaging changes in individuals with Down syndrome, who are at very high risk for development of Alzheimer's disease, even before the onset of progressive memory and thinking problems. Their findings could help set the stage to evaluate promising treatments to slow down or prevent the onset of Alzheimer's symptoms in these individuals, according to a study published in Alzheimer's & Dementia.
The scientists at Banner Sun Health Research Institute (BSHRI) and Banner Alzheimer's Institute (BAI) have also identified the approximate age--about 35 to 40--at which Alzheimer's-associated brain imaging changes occur in the Down's population, which could help pinpoint when to initiate investigational treatments in those trials.
Almost 80 percent of Down syndrome individuals will develop Alzheimer's, due partly to improved medical care that has led people with Down's to live longer and develop Alzheimer's-related brain changes. Down syndrome, also known as Trisomy 21, is caused when people have three copies of the twenty-first chromosome, which carries a gene for the amyloid precursor protein (APP). This results in over-expression of APP, leading to the over-production of amyloid, a protein linked to Alzheimer's disease, the deposition of amyloid plaques, and the development of memory and thinking problems at relatively young ages.
"The number of people with Down syndrome who go on to Alzheimer's symptoms has tripled in the last twenty years," said Marwan Sabbagh, the study's lead researcher and director of BSHRI. "There is a growing need to find interventions to treat and prevent Alzheimer's in these individuals, and there is an opportunity to do so in a way that could help find effective Alzheimer's prevention therapies for everyone."
Sabbagh and his team used positron emission tomography (PET) imaging to detect the accumulation of beta-amyloid, as well as a pattern of reduced brain activity that is characteristic of Alzheimer's disease. In addition, magnetic resonance imaging (MRI) scans were used to measure gray matter volume in three types of study participants: five participants with Down syndrome who already demonstrate clinical features of Alzheimer's, 12 participants with Down syndrome who have not yet shown clinical evidence of Alzheimer's and nine healthy participants who did not have either Down syndrome or Alzheimer's.
"We and other researchers have been interested in detecting and tracking Alzheimer's, starting before the onset of cognitive impairment in individuals at genetic risk for the disease," said Eric Reiman, M.D., executive director of BAI, a leader of the Alzheimer's Prevention Initiative (API), and senior researcher for this study. "We have used this approach to help launch Alzheimer's prevention trials in people with other genetic risk factors, and we hope that the same approach can help empower people with Down syndrome in the fight against this disease."
Comparing the three groups, researchers found that the Down syndrome with Alzheimer's group had significantly higher accumulation of beta-amyloid, lower brain activity in brain regions known to be affected by Alzheimer's and smaller gray matter volumes than the other two groups.
In comparing measurements between the group with Down syndrome without Alzheimer's dementia and the healthy volunteer group, researchers also found more accumulation of amyloid protein in the Down syndrome participants, even though these participants were not yet exhibiting Alzheimer's symptoms. This finding is consistent with previous evidence showing that amyloid deposition precedes clinical symptoms of Alzheimer's.
The findings led Sabbagh and his team to conclude that amyloid deposition begins around 35 to 40 years of age, before the onset of progressive memory and thinking problems.
The research team has received financial support to determine how these and other brain imaging and cognitive features of Alzheimer's disease change over time in people with Down syndrome, information that will help inform the design of future prevention trials in this population.
INFORMATION:
About Banner Sun Health Research Institute
Since 1986, Banner Sun Health Research Institute, part of nonprofit Banner Health, has been a leader nationally and internationally in the effort to find answers to disorders of aging including Alzheimer's and Parkinson's disease. The institute, together with its Arizona Alzheimer's Consortium partners, has been designated by the National Institutes of Health as one of just 29 Alzheimer's Disease Centers in the nation. The institute's Cleo Roberts Center for Clinical Research takes laboratory discoveries to clinical trials that foster hope for new treatments. Banner Health is Arizona's leading health care provider and second largest private employer. For more information, visit http://www.bannershri.org.
About Banner Alzheimer's Institute
Through its research and care, Banner Alzheimer's Institute (BAI) is dedicated to the goal of ending Alzheimer's disease without losing another generation. It is helping to launch a new era of Alzheimer's research--treatment and prevention at the pre-symptomatic stage--and to establish a new comprehensive model of care. Established in 2006 by Banner Health, one of the country's largest nonprofit health care systems, BAI has a three-fold focus: to conduct revolutionary studies in the detection, treatment and prevention of Alzheimer's; to set a national standard of patient and family care; and to forge scientific collaborations that bring together institutions and disciplines internationally.
The Alzheimer's Prevention Initiative (API) is an international collaborative formed to launch a new era of Alzheimer's prevention research. Led by the Banner Alzheimer's Institute, the API will conduct prevention trials in cognitively healthy people at increased genetic risk for Alzheimer's disease. For more information, visit http://www.banneralz.org.
Composite materials used in aircraft wings and fuselages are typically manufactured in large, industrial-sized ovens: Multiple polymer layers are blasted with temperatures up to 750 degrees Fahrenheit, and solidified to form a solid, resilient material. Using this approach, considerable energy is required first to heat the oven, then the gas around it, and finally the actual composite.
Aerospace engineers at MIT have now developed a carbon nanotube (CNT) film that can heat and solidify a composite without the need for massive ovens. When connected to an electrical power ...
WASHINGTON, DC - April 14, 2015 - A new study has demonstrated that genetically modified Salmonella can be used to kill cancer cells. The study is published in this week's issue of mBio, an American Society for Microbiology online-only, open access journal.
"There has long been interest in using genetically engineered microbes to target and destroy cells within solid tumors. I think this study goes a significant way in developing some strategies that will help in the overall means of using Salmonella as part of a cancer therapy," said Roy Curtiss, III, PhD, who was involved ...
LOS ANGELES (EMBARGOED UNTIL 7 A.M. EDT on APRIL 14, 2015) - An injection of stem cells into the eye may soon slow or reverse the effects of early-stage age-related macular degeneration, according to new research from scientists at Cedars-Sinai. Currently, there is no treatment that slows the progression of the disease, which is the leading cause of vision loss in people over 65.
"This is the first study to show preservation of vision after a single injection of adult-derived human cells into a rat model with age-related macular degeneration," said Shaomei Wang, MD, ...
Scientists at the University of Southampton have shown that higher muscle mass is strongly linked with healthier bone development in children.
Researchers also found no relationship between fat mass and bone development, indicating it is not an important factor in childhood skeletal strength.
A new study, published in the journal Bone, by researchers from the University's Medical Research Council Lifecourse Epidemiology Unit shows a link between the amount of lean muscle and healthy bone development, indicated by the size, shape and density of limb bones, in children ...
Methane, a highly effective greenhouse gas, is usually produced by decomposition of organic material, a complex process involving bacteria and microbes.
But there is another type of methane that can appear under specific circumstances: Abiotic methane is formed by chemical reactions in the oceanic crust beneath the seafloor.
New findings show that deep water gas hydrates, icy substances in the sediments that trap huge amounts of the methane, can be a reservoir for abiotic methane. One such reservoir was recently discovered on the ultraslow spreading Knipovich ridge, ...
Researchers at Uppsala University have, together with researchers from Turku and Bergen, discovered a new biomarker which makes it possible to identify women with uterine cancer who have a high risk of recurrence. The findings were recently published in the journal Gynecologic Oncology.
Endometrial cancer of the uterus is the most common form of gynecologic cancer in Europe and North America. The treatment primarily consists of removing the uterus and in some cases offering chemotherapy if the risk of recurrence is deemed high.
The current study looks at the amount ...
Researchers at the University of Manchester and Central Manchester University Hospitals NHS Foundation Trust have published data for the first time about public knowledge of and interest in the process of medicines research and development.
The study, which is part of the wider European Patients' Academy on Therapeutic Innovation (EUPATI) project, is believed to be the largest peer-reviewed survey of its kind and was published today in the BMJ Open.
Medicines R&D describes the entire process of bringing a new medicine to patients - from laboratory studies to clinical ...
The seabed is inhabited by vast numbers of small animals with hidden lives in the sandy sediments. Here they play an important role in keeping the oceans healthy. But how these animals behave and interact with each other is unclear, as it is not possible to see them without disturbing the sediment.
Researchers like Ph.D. Matthieu Delefosse would enjoy putting on a pair of X-ray glasses and study the sediment living animals without disturbing them.
"We know bits and pieces of what these animals do through different measurements/experiments, but we do not have an integrated ...
Researchers at Genes and Cancer group at Bellvitge Biomedical Research Institute (IDIBELL), led by Montse Sanchez-Cespedes, have identified the PARD3 gene as a tumor suppressor that is inactivated in lung cancer squamous type. The results of the study have been published in Cancer Research.
Correct polarization (orientation in space) of bronchial epithelial cells is essential for the maintenance and proper development of this tissue under normal conditions.
PARD3 gene encodes a protein that regulates cell polarization and cell junctions. When the gene is inactivated, ...
Scientists at the University of Sheffield calculate that all of the UK's high level nuclear waste from spent fuel reprocessing could be disposed of in just six boreholes 5km deep, fitting within a site no larger than a football pitch.
The concept - called deep borehole disposal - has been developed primarily in the UK but is likely to see its first field trials in the USA next year. If the trials are successful, the USA hopes to dispose of its 'hottest' and most radioactive waste - left over from plutonium production and currently stored at Hanford in Washington State ...
